Le Lézard
Classified in: Ebola virus, Covid-19 virus

AHF: ?Gilead: We Told You So on COVID Drug Pricing!'


AIDS Healthcare Foundation (AHF) today praised the 34 state attorneys general for taking action to bring down the cost and increase the supply of Gilead Sciences' remdesivir, the only approved treatment for COVID-19, the novel coronavirus.

"The August 4 letter from the attorneys general basically echoes and implements what AHF has been saying since as far back as March 30, that since taxpayers paid for the research and development?and are now paying for the production of this essential medicine?the price should be reasonable," said Tom Myers, general counsel and chief of public affairs for AHF.

In May, Gilead, which developed the drug years earlier (with as much as $70 million in government research and development funding) as a possible Ebola treatment, announced that it would set the price for remdesivir between $2,300 and $3,100 per patient for a five-day course of treatment. AHF issued a statement demanding that Gilead price the drug at no more than one dollar per day.

AHF's dollar per dose demand is based on a University of Liverpool research study, "Minimum costs to manufacture new treatments for COVID-19," that allows for recovery of the cost of manufacturing plus a reasonable profit.

"We applaud these state elected officials for standing up to Gilead's greed and thank them for taking this action," added John Hassell, national advocacy director for AHF.

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.4 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.


These press releases may also interest you

at 14:22
Since the beginning of the pandemic, action has been taken at all levels to protect the most vulnerable and support those who need it most. Collective measures have been taken by women's groups, homeless shelters, and mental health organizations, and...

at 14:21
Columbus-based STARK Industries, LLC has contributed to a new exhibit at Space Center Houston, highlighting?how NASA continues?to innovate to overcome obstacles and benefit humanity during the COVID-19 pandemic. NASA's Jet Propulsion Laboratory in...

at 14:15
The U.S. life/health industry saw more credit rating upgrades than downgrades in first-half 2020, driven primarily by improved levels of risk-adjusted capitalization. However, according to a new AM Best special report, negative rating actions could...

at 14:15
Giga-tronics Incorporated (the "Company") today announced the appointment of Thomas E. Vickers to its Board of Directors. Mr. Vickers has more than 35 years of experience in corporate finance and operations management. Presently, he is the...

at 14:10
Crystal IS, an Asahi Kasei company, and Boston University's National Emerging Infectious Diseases Laboratories (NEIDL) have performed research demonstrating the efficacy of Crystal IS' Klaran UVC LEDs to inactivate SARS-CoV-2. Crystal IS initiated...

at 14:10
Applied Biology in collaboration with researchers at University Hospital Ramon y Cajal in Madrid, Spain, today announced results from their androgen receptor genetics study in hospitalized COVID-19 male patients (NCT04368897,...



News published on 4 august 2020 at 19:30 and distributed by: